MY198417A - Use of Carbamate Compound for Preventing, Alleviating, or Treating Tremors or Tremor Syndrome - Google Patents
Use of Carbamate Compound for Preventing, Alleviating, or Treating Tremors or Tremor SyndromeInfo
- Publication number
- MY198417A MY198417A MYPI2019003351A MYPI2019003351A MY198417A MY 198417 A MY198417 A MY 198417A MY PI2019003351 A MYPI2019003351 A MY PI2019003351A MY PI2019003351 A MYPI2019003351 A MY PI2019003351A MY 198417 A MY198417 A MY 198417A
- Authority
- MY
- Malaysia
- Prior art keywords
- alleviating
- preventing
- carbamate compound
- tremor syndrome
- tremors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160170225 | 2016-12-14 | ||
| PCT/KR2017/014743 WO2018111009A1 (ko) | 2016-12-14 | 2017-12-14 | 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY198417A true MY198417A (en) | 2023-08-29 |
Family
ID=62558966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2019003351A MY198417A (en) | 2016-12-14 | 2017-12-14 | Use of Carbamate Compound for Preventing, Alleviating, or Treating Tremors or Tremor Syndrome |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11033531B2 (enExample) |
| EP (1) | EP3556364B1 (enExample) |
| JP (1) | JP7086076B2 (enExample) |
| KR (1) | KR102635941B1 (enExample) |
| CN (1) | CN110267657B (enExample) |
| AU (1) | AU2017374459B2 (enExample) |
| CL (1) | CL2019001623A1 (enExample) |
| ES (1) | ES3039979T3 (enExample) |
| IL (1) | IL267191B2 (enExample) |
| MX (1) | MX391363B (enExample) |
| MY (1) | MY198417A (enExample) |
| WO (1) | WO2018111009A1 (enExample) |
| ZA (1) | ZA201903749B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2973111T3 (es) * | 2017-11-14 | 2024-06-18 | Sk Biopharmaceuticals Co Ltd | Uso de un compuesto de carbamato para prevenir o tratar enfermedades asociadas con el aumento de la corriente tardía de sodio |
| IL281559B2 (en) * | 2018-09-21 | 2025-06-01 | Sk Biopharmaceuticals Co Ltd | (r)-1-phenyl-2-tetrazolyl ethyl carbamate derivatives and formulations comprising same for use in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS50676B (sr) * | 2001-02-27 | 2010-06-30 | Ortho-Mcneil Pharmaceutical Inc. | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja |
| WO2005097136A1 (en) * | 2004-03-29 | 2005-10-20 | Merck & Co., Inc. | Biaryl substituted pyrazinones as sodium channel blockers |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| EP2114393B1 (en) * | 2007-03-05 | 2013-04-17 | Indus Biotech Private Limited | Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| AU2009348523B2 (en) * | 2009-06-22 | 2015-02-26 | Sk Biopharmaceuticals Co., Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| JP6062077B2 (ja) * | 2013-03-12 | 2017-01-18 | バイオ−ファーム ソリューションズ カンパニー リミテッド | 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄｓｆｏｒｕｓｅｉｎｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇｐｅｄｉａｔｒｉｃｅｐｉｌｅｓｙａｎｄｅｐｉｌｅｓｙ−ｒｅｌａｔｅｄｓｙｎｄｒｏｍｅｓ｝ |
| KR102489052B1 (ko) * | 2016-05-19 | 2023-01-16 | 에스케이바이오팜 주식회사 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
-
2017
- 2017-12-14 KR KR1020197018409A patent/KR102635941B1/ko active Active
- 2017-12-14 JP JP2019531817A patent/JP7086076B2/ja active Active
- 2017-12-14 EP EP17880232.8A patent/EP3556364B1/en active Active
- 2017-12-14 ES ES17880232T patent/ES3039979T3/es active Active
- 2017-12-14 MY MYPI2019003351A patent/MY198417A/en unknown
- 2017-12-14 MX MX2019006941A patent/MX391363B/es unknown
- 2017-12-14 CN CN201780077642.3A patent/CN110267657B/zh active Active
- 2017-12-14 WO PCT/KR2017/014743 patent/WO2018111009A1/ko not_active Ceased
- 2017-12-14 AU AU2017374459A patent/AU2017374459B2/en active Active
- 2017-12-14 US US16/468,936 patent/US11033531B2/en active Active
-
2019
- 2019-06-10 IL IL267191A patent/IL267191B2/en unknown
- 2019-06-11 ZA ZA2019/03749A patent/ZA201903749B/en unknown
- 2019-06-12 CL CL2019001623A patent/CL2019001623A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102635941B1 (ko) | 2024-02-13 |
| KR20190087573A (ko) | 2019-07-24 |
| RU2019121914A (ru) | 2021-01-15 |
| IL267191B1 (en) | 2023-01-01 |
| CN110267657A (zh) | 2019-09-20 |
| CA3046300A1 (en) | 2018-06-21 |
| MX2019006941A (es) | 2019-09-06 |
| CN110267657B (zh) | 2022-12-13 |
| CL2019001623A1 (es) | 2019-08-23 |
| EP3556364B1 (en) | 2025-08-27 |
| AU2017374459B2 (en) | 2023-04-27 |
| IL267191B2 (en) | 2023-05-01 |
| EP3556364A1 (en) | 2019-10-23 |
| JP2020502137A (ja) | 2020-01-23 |
| BR112019012000A2 (pt) | 2019-10-29 |
| RU2019121914A3 (enExample) | 2021-04-21 |
| ZA201903749B (en) | 2022-01-26 |
| US11033531B2 (en) | 2021-06-15 |
| EP3556364A4 (en) | 2020-06-17 |
| AU2017374459A1 (en) | 2019-07-04 |
| MX391363B (es) | 2025-03-21 |
| WO2018111009A1 (ko) | 2018-06-21 |
| ES3039979T3 (en) | 2025-10-28 |
| JP7086076B2 (ja) | 2022-06-17 |
| US20190336481A1 (en) | 2019-11-07 |
| IL267191A (enExample) | 2019-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022012317A (es) | Oxisteroles y metodos de uso de los mismos. | |
| WO2017204445A3 (ko) | Alk 단백질의 분해를 유도하는 약학적 조성물 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 | |
| BR112017003658A2 (pt) | composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica. | |
| MX2018005041A (es) | Compuestos para tratar la esclerosis lateral amiotrofica. | |
| MY196186A (en) | Amino-Fluoropiperidine Derivatitves as Kinase Inhibitor | |
| MY194468A (en) | Oxy-fluoropiperidine derivatives as kinase inhhiitor | |
| MX2016003582A (es) | Compuesto inhibidor de las actividades de las cinasas btk y/o jak3. | |
| PH12017500416A1 (en) | Compounds and compositions as raf kinase inhibitors | |
| PH12021500034A1 (en) | Compounds useful in hiv therapy | |
| PH12019501690A1 (en) | Pyrimidine compound and pharmaceutical use thereof | |
| PH12021550713A1 (en) | Medicament for the treatment of chronic cough | |
| SG10201907291QA (en) | Monomethylfumarate prodrug compositions | |
| MX394245B (es) | Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. | |
| PH12020551117A1 (en) | Compositions for preventing or treating uveitis | |
| PH12017501130A1 (en) | Indenyl compounds, pharmaceutical compositions, and medical uses thereof | |
| MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. | |
| MX2017013281A (es) | Metodos para tratar transtornos del almacenamiento lisosomal. | |
| MY199104A (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| MX2018016339A (es) | Compuestos heterociclicos antiinfecciosos y sus usos. | |
| MX389613B (es) | Uso de compuesto de carbamato para prevenir o tratar neuralgia trigeminal. | |
| PH12020550549A1 (en) | Compositions for preventing or treating lupus | |
| MX2019006941A (es) | Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor. | |
| PH12017501560A1 (en) | Tetrahydropyranyl benzamide derivatives | |
| MX2020000144A (es) | Composicion farmaceutica para administracion nasal. | |
| MX2021003203A (es) | Compuesto de carbamato y uso de la formulacion que comprende el mismo en prevenir, aliviar, o tratar trastorno de estres agudo o trastorno de estres post-traumatico. |